Suprenamin
Adrenal cytamin — Khavinson-school organ peptide fraction, oral tablet
Suprenamin (Adrenal cytamin — Khavinson-school organ peptide fraction, oral tablet) is a longevity & bioregulators research compound. A polypeptide fraction extracted from animal adrenal tissue, 155mg per tablet. Every other organ in this line has at least one experiment behind it — brain, pineal, liver, thymus, heart, lung, prostate, pancreas, cartilage, kidney, vessels. The adrenal gland has none. A PubTator3 search of PubMed for peptide bioregulators and the adrenal cortex, run 8 September 2026, returned zero records, so the tissue-specificity claim has never been tested on the organ this product names.
Suprenamin quick facts
| Route | Oral |
| Frequency | Not established · Not established |
| Half-life | Not characterized — no analytical method for this preparation has been published |
| Forms | Oral |
| Evidence level | No published study of this product, and no study of this school's peptides on adrenal tissue at all. |
This is bought for a state that is not a diagnosis. Adrenal fatigue is not a recognized clinical entity, and the measurements that describe real adrenal function — morning cortisol, ACTH, DHEA-S — are ordinary tests that would settle in one draw whether anything moved. The two Russian papers that name the cytamin class in humans studied servicemen and athletes and neither reported a cortisol measurement. Of the seventeen products in this line, this is the one whose organ has no experiment behind it at all.
How Suprenamin works
A polypeptide fraction extracted from animal adrenal tissue, 155mg per tablet. Every other organ in this line has at least one experiment behind it — brain, pineal, liver, thymus, heart, lung, prostate, pancreas, cartilage, kidney, vessels. The adrenal gland has none. A PubTator3 search of PubMed for peptide bioregulators and the adrenal cortex, run 8 September 2026, returned zero records, so the tissue-specificity claim has never been tested on the organ this product names.
Proposed benefits
Researched for mitochondrial and cellular-energy support, tissue-specific bioregulation and healthy-aging pathways.
Where to get Suprenamin
Buy Suprenamin at RUPharma →The evidence for Suprenamin
Graded by what exists behind each claim.
✅ Clinically validated
- None. A PubTator3 search for this product's name on 8 September 2026 returned one record, and it is a class paper about cytamines in athletes rather than a study of this tablet.
📊 Correlative data
- The two human papers naming this class are Russian: cytamines for professional ability and longevity in servicemen (Khavinson 2001) and cytamines with ecdystene, apilak, vitamax and essentiale on the work capability of athletes (Emirova 2004). Neither reports a cortisol measurement.
🧪 Theoretical / extrapolated
- This is the one organ in the line with no experiment behind it. The tissue-specificity claim has been tested in dishes on brain, pineal, liver, thymus, heart, lung, prostate, pancreas and cartilage. A search for peptide bioregulators and the adrenal cortex on 8 September 2026 returned zero records.
- The adrenal cortex makes steroid hormones, which are small, heat-stable and orally active where peptides are not. Whether any steroid activity survives into the tablet is the one mechanistically interesting question this product raises, and nobody has published the assay.
- Morning cortisol, ACTH and DHEA-S are ordinary tests that would settle it in one draw. Adrenal fatigue is not a recognized clinical entity, and real adrenal insufficiency is treated rather than supplemented.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What Suprenamin actually does
Seventeen organ names, and this is the one with no experiment behind it. The tissue-specificity claim in this school has been tested, in dishes, on brain, pineal, liver, thymus, heart, lung, prostate, pancreas and cartilage Zakutskiĭ 2006 Ryzhak 2015. A PubTator3 query for peptide bioregulators and the adrenal cortex, run 8 September 2026, returned zero records. The adrenal gland is absent from the school's own supporting literature, which means the premise of the product line has never been tested on the organ this product names.
What is in the pack. A 155 mg tablet of a nucleoprotein fraction extracted from animal adrenal tissue, 40 to a pack, at $42. No composition published, no assay, no dissolution profile, no analytical method. Ryzhak 2003 describes the class's manufacturing and its infectious-agent screening, and reports nothing about what a finished adrenal tablet contains.
The one chemical fact that makes an adrenal extract different from every other tablet on this shelf. The adrenal cortex synthesizes steroid hormones — cortisol, aldosterone, dehydroepiandrosterone. Steroids are small, lipid-soluble, heat-stable molecules that survive processes protein does not, and they are orally active, which peptides are not. So the question a buyer would want answered for this product and no other is whether any steroid activity survives into the tablet. Nobody has published that analysis. The expectation is that a defatted aqueous fraction carries little to none; the point is that expectation is all there is.
What the class claim would have to mean here. Tissue-specific regulation of gene expression Khavinson 2021, applied to the adrenal, means changed steroidogenic enzyme expression or changed responsiveness to adrenocorticotropic hormone. Both are measurable. Neither has been measured for this product, or for any peptide preparation from this school, in any species.
Cell, rodent, human — and where it stops
Corrected 9 September 2026, and the correction runs against this page. A PubTator3 query for suprenamin returns one record, Emirova 2004. This page originally called it a class paper rather than a study of this product. Its abstract opens by naming the three cytamins that were given — hepatamin, epifamin and suprenamin. The adrenal tablet is one of them. Reading a title as a class label without opening the abstract is exactly the error this cohort exists to prevent, and it was made here in the direction of understatement.
What that paper can and cannot carry. It reports that those three cytamins, in various combinations with ecdystene, apilak, vitamax and essentiale, increased the working ability of high-ranking athletes. The abstract states no sample size, no randomization, no blinding, no placebo, no effect size and no endpoint definition, and no regimen in it is this tablet alone. So the correct claim is narrow: this product has been given to people and written up favorably, in combination, in a form that cannot be checked. It is not a trial and it is not nothing, and the difference between those two descriptions is the whole reason to read an abstract before citing a title.
The rest of the searches stand. A query for peptide bioregulators and the adrenal cortex returns zero. There is no pharmacokinetic study of this tablet, no case series, and no adrenal experiment anywhere in this school — which remains the central fact about it, because a named appearance in a combination study is not an experiment on the adrenal gland.
The two human papers, described accurately. Khavinson 2001 is Khavinson and colleagues in a Russian military medical journal in 2001, on cytamines for maintaining professional ability and longevity in servicemen. Emirova 2004 is a 2004 Russian pharmacology paper testing cytamines alone and combined with ecdystene, apilak, vitamax and essentiale on athletes' work capability, reporting improved exercise tolerance and potentiation of the other agents. The 2001 note names no individual product and PubTator3 returns no abstract for it; the 2004 paper names this one. What neither reports is a cortisol measurement — which is the measurement an adrenal product exists to change, and the reason a named appearance in an exercise-tolerance study leaves this page's argument standing.
The same group's follow-up, and what it swapped in. Rozhkova 2007 comes from the athletics laboratory behind the 2004 paper and addresses post-exercise oxidative stress using carnosine and natural antioxidants, described as non-doping aids to recovery. Three years after the cytamine work, the same group is writing about carnosine. That is not proof the cytamines failed; it is the shape a research line takes when it does not continue.
The gap between the product and the reason people buy it. This tablet is bought for a state described as adrenal fatigue. That is not a recognized clinical entity, and describing it as one would be the site making a diagnosis, which it does not do. What is real is that fatigue has causes that are measurable, that some of them are adrenal and most are not, and that the tests which distinguish them are ordinary.
Suprenamin pharmacokinetics — how much of it actually gets in
What degrades it. Gastric acid, pepsin, pancreatic proteases and brush-border peptidases, in that order, reducing a nucleoprotein fraction to amino acids and short peptides. Standard for every tablet in this line and unclaimed against by any vendor of this one.
The oral barrier, and the asymmetry that matters for an adrenal product. Peptides need saturable carriers to cross the gut wall and most of the dose does not arrive intact, and no oral bioavailability figure has been published for this preparation. Steroids do not: they are absorbed passively and are orally active, which is why the unmeasured steroid content of this specific extract is the only pharmacokinetically interesting question it raises. A peptide argument and a steroid argument have opposite absorption profiles, and only one of them has been assayed for this product, which is neither.
The arithmetic. A 155 mg tablet dissolved intact into 5 liters of blood is about 31 µg/ml; the explant work operated at 0.01-100 ng/ml Ryzhak 2015, so even a small absorbed fraction is numerically in range. For comparison, a physiologic cortisol replacement dose is on the order of 15-25 mg per day of an orally active steroid — so if even 0.1% of this tablet's mass were glucocorticoid activity, that would be a pharmacologically trivial 155 µg. The numbers are reassuring and they are still arithmetic rather than an assay.
No half-life, and no injectable comparator. No analytical method has been published for this preparation, so no plasma curve exists. There is no injected adrenal extract in this catalog to set a ceiling against, unlike the brain arm of the family where a radiolabeled injection at least produced a number. Any effect would follow the timescale of a protein meal, which makes the 40-tablet pack a schedule and not an accumulation.
What would have to be true, and how you would know it was not
Four predictions, and the first three are one blood draw.
1. Morning cortisol, drawn between 7 and 9 am, before and after. Timing is the whole test: cortisol has a steep diurnal curve and a random afternoon draw is close to uninterpretable. It is a standard assay available everywhere. Zero published records of this product report it. Prediction: no change.
2. ACTH from the same draw. Pairing adrenocorticotropic hormone with cortisol is what separates an adrenal problem from a pituitary one, and it is the pairing that makes the result interpretable rather than merely a number. If a genuinely adrenal effect existed, this pair is where it would appear.
3. DHEA-S, which is the adrenal marker this readership already orders. It is stable across the day, it is almost entirely adrenal in origin, and it declines with age, which is exactly the narrative this product is sold into. Prediction: unchanged by the tablet. That prediction has never been tested.
4. Against the product, and it is the strongest claim on this page. If the tissue-specificity premise is true, an adrenal extract should differ from a kidney extract on an adrenal endpoint. The school has tested that premise on nine tissues and never on this one. Until somebody runs a single explant experiment on adrenal tissue, this product is the only one in the line whose central claim has not been tested even in a dish.
What nobody has tested yet
Nobody has assayed a tablet for steroid content. Liquid chromatography-tandem mass spectrometry for cortisol, dehydroepiandrosterone and aldosterone in a dissolved tablet is a routine analytical run costing a few hundred dollars. It is the single most useful measurement anyone could make on this product, it would settle the only mechanistically interesting question it raises, and no vendor or independent laboratory has published it.
Nobody has run the explant experiment on adrenal tissue. Zakutskiĭ 2006 is a published protocol that has been applied to four organs and Ryzhak 2015 to several more. Adding adrenal explants would take one experiment and would give this product line its first adrenal data of any kind.
Nobody has measured cortisol in the two human studies that exist. Khavinson 2001 and Emirova 2004 both studied populations under physical and occupational stress, which is the exact population in which an adrenal endpoint would have been cheap to add and informative to report. Neither reports one.
Extrapolation, labeled as such. If the active species are short peptides released by digestion, then adrenal tissue offers no reason to expect a different peptide profile from any other soft tissue, and the product's distinguishing feature would be its steroid content rather than its peptides. That is a testable reframing of the whole product and nobody has tested it.
Suprenamin — its own safety story, not its class's
Three things specific to an oral extract of animal adrenal tissue.
The unmeasured steroid question cuts both ways. If a tablet of adrenal cortex carried meaningful glucocorticoid activity, the hazard would not be that it works — it would be that a person taking it daily for months has an unmonitored steroid exposure and a suppressed axis they do not know about. The arithmetic above suggests the quantities are trivial. Nobody has run the assay that would turn that suggestion into a fact, and that is the honest state of it.
The empty adverse-event column, and what it is not. Zero published studies means zero published adverse events. For this product the zero is doubled: no study of the tablet, and no experiment on adrenal tissue anywhere in the school. It is the thinnest evidence position of any page in this cohort.
Persistent fatigue is a symptom with causes worth finding. Anemia, thyroid disease, sleep apnea, depression, iron deficiency and genuine adrenal insufficiency all present as tiredness, and they are separated by ordinary tests rather than by a supplement. Real adrenal insufficiency is a serious condition that is treated, not supplemented. Nothing on this page is a diagnosis or a substitute for one, and the reason to say that here rather than in a footnote is that this is the product most likely to be bought instead of an appointment.
Sources read for this page
- Khavinson VKh, Cherniak SI, D'iakonov MM. [Cytamines--preparations for maintaining high professional ability and longevity in servicemen]. Voenno-Meditsinskii Zhurnal 2001 [Russian] · PMID 11338817
- Emirova LR, Rozhkova EA, Paniushkin VV, Mirzoian RS, Seifulla NR. [The effects of cytamines and their combinations with ecdystene, apilak, vitamax, and essentiale on the work capability of athletes]. Eksperimental'naia i Klinicheskaia Farmakologiia 2004 [Russian] · PMID 15341074
- Rozhkova EA, Ordzhonikidze ZG, Druzhinin AE, Seifulla NR, Paniushkin VV, Kuznetsov IuM. [Using carnosine and natural antioxidants for the prophylaxis of acute post-loading oxidative stress]. Eksperimental'naia i Klinicheskaia Farmakologiia 2007 [Russian] · PMID 18074807
- Ryzhak GA, Nekrasov PA, Kiselev OI, Khavinson VKh. Study of protein components of natural peptide regulators. Bulletin of Experimental Biology and Medicine 2003 · PMID 12717513
- Khavinson VKh, Popovich IG, Linkova NS, Mironova ES, Ilina AR. Peptide Regulation of Gene Expression: A Systematic Review. Molecules 2021;26(22):7053 · PMID 34834147
- Ryzhak AP, Chalisova NI, Lin'kova NS, Khalimov RI, Ryzhak GA, Zhekalov AN. [Polypeptides influence on tissue cell cultures regeneration of various age rats]. Advances in Gerontology 2015;28(1):97-103 [Russian] · PMID 26390619
- Zakutskiĭ AN, et al. The tissue-specific effect of synthetic peptides-biologic regulators in organotypic tissues culture in young and old rats. Advances in Gerontology 2006 · PMID 17152728
Suprenamin — safety, predicted from mechanism
Predicted from mechanism, not from a human safety trial. How that reasoning works →
What the mechanism predicts
Derived from the molecule, not a trial.
- These are short peptide fragments of organ extracts, and the honest starting point is that the mechanism itself is not established in a way that lets anyone predict harm precisely. The proposal is gene-regulatory — short peptides binding DNA and modulating transcription in a tissue-specific way. If that is what they do, the theoretical concern is influencing transcription in tissue you were not aiming at.
- In practice the doses are tiny, the peptides are short, and they are degraded quickly — which is also the argument that they may do very little at all. Those two possibilities are the same uncertainty viewed from opposite ends, and you should hold both.
What has actually been reported
- Decades of Russian clinical use with a strikingly clean tolerability record — injection-site reactions and little else reported.
- That record comes almost entirely from one research school, is largely unreplicated outside it, and safety data from a group with an interest in the outcome is worth less than the same data from a skeptic. This is not an accusation; it is how evidence weighting works.
How to reduce the risk
Same mechanism as the prediction.
- Follow the course printed on the label rather than running continuously. These are the one class in the Vault where a duration is STATED rather than inferred, and it is typically 10–20 days repeated a few times a year. Read the box.
- Run one at a time. They are cheap and it is tempting to stack six. If something changes, a stack of six tells you nothing about which one did it — and given the evidence base, attribution is the entire value of your own experiment.
- Decide your endpoint before you start, and make it a marker or a measurable symptom rather than a feeling. With a compound class this under-evidenced, an unfalsifiable endpoint means you will conclude it worked no matter what happened.
- Buy from a source that publishes third-party testing. Where the molecule itself is uncertain, identity and purity are the only variables you can actually control.
What it does to your bloodwork
A fact about the assay.
- Test the ORGAN, not the peptide. A thymic peptide is judged on immune markers, a pineal one on sleep and IGF-1, a vascular one on lipids and inflammatory markers. There is no assay for the compound itself.
Don't run this if
- Pregnancy — not because of a specific finding, but because nobody has studied it and the mechanism claim is transcriptional.
- Active malignancy, on the same reasoning as any tissue-growth signal: unproven, mechanistically arguable, and not worth finding out.
The honest unknown
- Essentially everything a skeptic would want: independent replication, pharmacokinetics, and whether the oral forms survive digestion at all. Unproven is not the same as ineffective — but here it is a large unproven.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this with a pharmacist or doctor.
Suprenamin — interference & stacking
Predicted from mechanism, not from an interaction study. How mechanism-predicted claims are made →
What Suprenamin moves on your bloodwork
Expected direction, not a measured one.
- Comprehensive Metabolic Panel (CMP) — ◆ worth watching
These are short peptide fragments given in microgram amounts and there is no mechanism predicting a specific marker shift. Listing markers here would be padding.
What to do: Test the organ system the bioregulator is aimed at, not a generic panel — that is the only measurement that would tell you anything.
The evidence base here is almost entirely one research group's, largely in Russian, and rarely replicated independently. That is the single most important thing to know before running a course, and it is more useful than any interaction list.
- Dose range and how to work up to it
- When to take it, and why that window
- Cycle length
- Time off between cycles
- Fasted or fed, and when in the day
- Coach Cam's personal notes
- Which compounds push the same lever, and why the dose adds up faster than people count
- What blunts it — the stacks that waste your money
- What compounds the risk, so a side effect arrives sooner than any one of them suggests
- Coach Cam's read on running it alongside the rest of your protocol
Everything above is free and stays free. Skool is where it becomes a plan — Suprenamin in an order, with the rest of what you're running.
Unlock in Skool — $10/mo →Bloodwork to run alongside Suprenamin
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| hs-CRP (High-Sensitivity C-Reactive Protein) | Chronic low-grade inflammation is the process most of these target |
| ApoB (Apolipoprotein B) | Counts the particles that actually cause plaque, unlike LDL-C |
| HbA1c (Hemoglobin A1c) | Glycation, which is the other half of the ageing story |
| Comprehensive Metabolic Panel (CMP) | Liver and kidney — the two organs that clear everything you take |
| Complete Blood Count (CBC) with Differential | The cheapest broad screen there is |
The Longevity Baseline panel covers these in one order — 13 markers, $219.10 with the discount applied.
Check results you already have → · All 103 markers A–Z
Suprenamin — frequently asked questions
What is Suprenamin?
Suprenamin (Adrenal cytamin — Khavinson-school organ peptide fraction, oral tablet) is a longevity & bioregulators research compound. A polypeptide fraction extracted from animal adrenal tissue, 155mg per tablet. Every other organ in this line has at least one experiment behind it — brain, pineal, liver, thymus, heart, lung, prostate, pancreas, cartilage, kidney, vessels. The adrenal gland has none. A PubTator3 search of PubMed for peptide bioregulators and the adrenal cortex, run 8 September 2026, returned zero records, so the tissue-specificity claim has never been tested on the organ this product names.
Where can I find Suprenamin dosing and protocols?
Dosing, the reconstitution calculator and Coach Cam's full Suprenamin protocol are available to members inside Skool. This public page covers what Suprenamin is, how it works and the evidence.
What is the half-life of Suprenamin?
Suprenamin has an approximate half-life of Not characterized — no analytical method for this preparation has been published, which is part of what determines how often it's dosed.
What's the evidence behind Suprenamin?
Current evidence level: No published study of this product, and no study of this school's peptides on adrenal tissue at all.. Suprenamin is offered for research purposes only and is not an approved medicine.
What Suprenamin is used for
Suprenamin appears under 1 goal in the goal router.
Related Longevity & Bioregulators compounds
Where this goes next
The pages here are the frameworks. The protocols — the dosing, the order to correct things in, the week-by-week schedule and what to retest — are inside Skool.